DOCSLIB.ORG

2017 Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2017 Annual Report CONTENTS Corporate Information 2 Financial Highlights 4 Chairman’s Statement 5 Management Discussion and Analysis 7 Report of the Directors 24 Corporate Governance Report 39 Corporate Social Responsibility 56 Profiles of Directors, Supervisors and Senior Management 57 Independent Auditors’ Report 63 Consolidated Statement of Profit or Loss and Other Comprehensive Income 70 Consolidated Statement of Financial Position 71 Consolidated Statement of Changes in Equity 73 Consolidated Statement of Cash Flows 75 Notes to Financial Statements 77 Definitions 152 Glossary of Technical Terms 154 CORPORATE INFORMATION BOARD OF DIRECTORS AUDIT COMMITTEE Mr. Shen Hongbo (Chairman) Executive Directors: Ms. You Jie Dr. Hou Yongtai (Chairman) Mr. Chen Huabin Mr. Wu Jianying (General Manager) Mr. Li Yuanxu Mr. Huang Ming (Secretary of the Board) Mr. Zhu Qin Ms. Chen Yiyi Mr. Tang Minjie (Chief Financial Officer) REMUNERATION COMMITTEE Mr. Zhu Qin (Chairman) Non-executive Directors: Mr. Wu Jianying Ms. You Jie Mr. Huang Ming Mr. Gan Renbao Mr. Shen Hongbo Mr. Li Yuanxu Independent Non-executive Directors: Mr. Chen Huabin NOMINATION COMMITTEE Mr. Shen Hongbo Mr. Li Yuanxu (Chairman) Mr. Li Yuanxu Dr. Hou Yongtai Mr. Zhu Qin Ms. You Jie Mr. Wong Kwan Kit Mr. Chen Huabin Mr. Zhu Qin THIRD SESSION OF THE SUPERVISOR COMMITTEE STRATEGY COMMITTEE Mr. Liu Yuanzhong Ms. You Jie (Chairlady) Ms. Yang Qing Dr. Hou Yongtai Mr. Tang Yuejun Mr. Wu Jianying Mr. Wei Changzheng Mr. Huang Ming Mr. Yang Linfeng Mr. Li Yuanxu AUTHORIZED REPRESENTATIVES LEGAL ADVISERS Mr. Huang Ming Tiang & Co. Mr. Chiu Ming King Room 2010, 20/F, Edinburgh Tower JOINT COMPANY SECRETARIES The Landmark Mr. Huang Ming 15 Queen’s Road Central Mr. Chiu Ming King (a fellow member of the Hong Kong Hong Kong Institute of Chartered Secretaries) AUDITORS Ernst & Young Certified Public Accountants 22nd Floor, CITIC Tower 1 Tim Mei Avenue Central, Hong Kong 2 Shanghai Haohai Biological Technology Co., Ltd. CORPORATE INFORMATION HEADQUARTERS AND PRINCIPAL PLACE REGISTERED OFFICE OF BUSINESS IN THE PRC No. 5 Dongjing Road 23/F, WenGuang Plaza, No. 1386 Songjiang Industrial Zone Hongqiao Road, Changning District Shanghai, China Shanghai, China PRINCIPAL BANKERS PRINCIPAL PLACE OF BUSINESS IN Industrial and Commercial Bank of China Ltd. HONG KONG (Xinhua Road Sub-branch, Shanghai) Room 1901, 19/F No. 506 Xinhua Road Lee Garden One Changning District 33 Hysan Avenue Shanghai, China Causeway Bay, Hong Kong Bank of Shanghai, Co., Ltd H SHARE REGISTRAR (Changning Branch, Shanghai) Computershare Hong Kong Investor Services Limited No. 320 Xianxia Road Shops 1712-1716, 17th Floor Changning District Hopewell Centre Shanghai, China 183 Queen’s Road East Wan Chai, Hong Kong INVESTOR ENQUIRIES Investors’ Service Line: (86) 021-52293555 INFORMATION OF H SHARES Fax: (86) 021-52293558 Place of listing: The Main Board of The Stock Website: www.3healthcare.com Exchange of Hong Kong Limited Stock code: 6826 Number of H shares issued: 40,045,300 H shares Nominal value: RMB1.00 per H share Stock short name: HAOHAI BIOTEC Annual Report 2017 3 FINANCIAL HIGHLIGHTS 31 December 31 December 31 December 31 December 31 December 2017 2016 2015 2014 2013 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 Results of operation Revenue 1,344,856 851,157 663,917 515,940 401,088 Gross Profit 1,057,389 709,606 558,844 450,057 346,252 Profit before tax 461,621 365,885 320,647 215,616 166,467 Net profit attributable to shareholders of the parent 372,415 305,052 273,474 183,582 141,521 Profitability Gross profit margin 78.6% 83.4% 84.2% 87.2% 86.3% Net profit margin 27.7% 35.8% 41.2% 35.6% 35.3% Earnings per share (RMB) Basic earnings per share* 2.33 1.91 1.86 1.53 1.18 Assets Total assets 4,075,299 3,693,412 2,821,910 751,903 621,178 Total liabilities 708,594 707,552 156,476 157,743 90,600 Total equity attributable to ordinary equity holders of the parent 3,200,562 2,903,992 2,661,911 594,160 530,578 Gearing ratio 17.4% 19.2% 5.5% 21.0% 14.6% * Diluted earnings per share is the same as basic earnings per share as the Group had no potential dilutive ordinary shares in issue during the periods. 4 Shanghai Haohai Biological Technology Co., Ltd. CHAIRMAN’S STATEMENT Dear Shareholders, I herein represent the Group to present the annual performance of the Group for the year ended 31 December 2017. 2017 marked a significant year for the implementation of the spirit of the National Health and Well-being Convention and the “13th Five-Year Plan” for deepening the reforms of the pharmaceuticals and healthcare system. The frequent release of the national medical policies makes the industry face new important opportunities and challenges. During the Reporting Period, the Group recorded aggregate revenue of approximately RMB1,344.86 million, representing an increase of RMB493.70 million, or approximately 58.0%, as compared to that in 2016. During the Reporting Period, the profit attributable to ordinary equity holders of the Company was approximately RMB372.42 million, representing an increase of approximately 22.1% as compared to that in 2016. The amortisation charge attributable to ordinary equity holders of the Company on intangible assets from business acquisition of the Group (after tax) was approximately RMB12.50 million, after excluding the impact of such charge, the profit attributable to ordinary equity holders of the Company was approximately RMB384.92 million, representing an increase of approximately 25.6% as compared to that in 2016. Since 2016, the Group completed a number of acquisitions, including the acquisition of 60% equity interest in Shenzhen NIMO, 100% equity interest in Henan Universe, 100% equity interest in Zhuhai Eyegood and Aaren Business. Following these acquisitions, the Group completed the acquisition of 70% share capital in Contamac Holdings, a UK IOL, ophthalmic materials and technology supplier, during the Reporting Period, which will help the Group to secure long-term and stable upstream material supply and enhance the research and development of new IOL and other ophthalmic products. So far, the Group’s global whole industry chain layout centered on IOL products has been primarily established, which has laid an industry foundation for the long-term growth of the ophthalmic high-valued materials business in the future. On 23 February 2017, the Ministry of Human Resources and Social Security officially issued the 2017 National Reimbursement Drug List (“NRDL”), and upon experts’ appraisal, rhEGF “Healin” was reclassified to Class B medical insurance products by lifting the limitation on the work-related injury insurance products in the 2009 NRDL. Advanced jointly by the favourable policies and the Group’s efforts on marketing, the Group’s revenue from the sales of “Healin” products rapidly increased to approximately RMB53.03 million for the Reporting Period from approximately RMB37.52 million in 2016, representing an increase of 41.3%. During the Reporting Period, our sodium hyaluronate injection product with a new specification of 2.5ml has been approved by the CFDA, making the Group the only enterprise having sodium hyaluronate injection products with full series of specifications of 2ml, 2.5ml and 3ml in the PRC market. The management of the Company believes that the approval of the new specification will help the Group to gain new strengths in the intense market competition. Annual Report 2017 5 CHAIRMAN’S STATEMENT During the Reporting Period, the Group continued to enlarge its R&D investments and focus on the technological innovation. The project on “Research & Development of New Intraocular Lens and High-end Ophthalmic Implant Materials” led by the Group was successfully selected in the National Key Research and Development Programs under the “13th Five-Year Plan”, which will offer in-depth support to the Group on improving the quality and market competitiveness of domestic IOL products and then realizing its strategic plan related to replacing the imported products. As at the date of this annual report, the Company, as the only bio-medicine enterprise in Shanghai, has been included on the Proposed List of National Enterprise Technology Centers released by the National Development and Reform Commission, making the Company the first Shanghai bio-medicine enterprise enlisted ever since 2015. The year of 2018 will still be a year full of challenges, however, we believe that current reforms, enterprises benefiting from the advantage of scale and in possession of advanced technologies, well established brands, marketing competitive edge and industrial integration capabilities will experience invaluable development opportunities. In conclusion, on behalf of the Board, I would like to express the sincere gratitude to our staff and management team, customers and Shareholders for their ongoing support. And we look forward to heading to a new year with fruitful results along with you. Hou Yongtai Executive Director and Chairman of the Board 26 March 2018 6 Shanghai Haohai Biological Technology Co., Ltd. MANAGEMENT DISCUSSION AND ANALYSIS BUSINESS REVIEW AND PROSPECT 2017 marked a significant year for the implementation of the spirit of the National Health and Well-being Convention and the “13th Five-Year Plan” for deepening the reforms of the pharmaceuticals and healthcare system. In 2017, the consecutive introduction of major policies for the pharmaceutical and medical device industry in China since 2015 continued to affect the whole industry, and the reform policies released during the Reporting Period covered almost all of the sub-sectors under the four major sectors including pharmaceuticals, healthcare, medical insurance and circulation, which created severe challenges for the enterprises within the industry, while on the other hand, important develop opportunities also emerged. During the Reporting Period, the Group offered responses to the reforms.
Load more

Recommended publications
  • Analyzing the Influence of Major Actors in China's Renewable
    Analyzing the Influence of Major Actors in China’s Renewable Energy Policy Process as a Means of Predicting Future Chinese Renewable Energy Policy Trends By Michelle Hung Wai Lee A thesis submitted In partial fulfillment of the requirements For the degree of Masters of Science (Natural Resources and Environment) In the University of Michigan April 2012 Thesis Committee: Ming Xu, Assistant Professor (Chair) Shaopeng Huang, Associate Research Scientist Acknowledgements The author expresses thanks to her Thesis Advisors, Assistant Professor Xu Ming and Associate Research Scientist Huang Shaopeng; as well as Associate Professor Mary Gallagher from the Center for Chinese Studies; and Assistant Professor Yuen Yuen Ang from the Department of Political Science for their invaluable advice, patience and guidance. Special thanks to my parents, for supporting me through Graduate School. Any errors in this thesis are the author’s own. i Abstract This thesis identified seven major actors involved in the renewable energy policy process in China, and evaluated their relative levels of influence over the entire process, from drafting to implementation. The research aimed to tease out important actors and their means of influencing policy. The thesis employed a policy analysis framework adapted from Yaffee (2011) that observes each actor’s motivations, resources and strategies. The research revealed that the Chinese Communist Party still possesses the greatest amount of influence over policy-making, followed by government sponsored think tanks. Market-based enterprises—central state-owned enterprises (SOEs) and private firms—as well as the local government are a significant force. Ministries brought up the rear. The results are in contrast to a theoretical understanding of flows of power and influence in Chinese politics.
    [Show full text]
  • List of Buildings with Confirmed / Probable Cases of COVID-19
    List of Buildings With Confirmed / Probable Cases of COVID-19 List of Residential Buildings in Which Confirmed / Probable Cases Have Resided (Note: The buildings will remain on the list for 14 days since the reported date.) Related Confirmed / District Building Name Probable Case(s) Islands Hong Kong Skycity Marriott Hotel 5482 Islands Hong Kong Skycity Marriott Hotel 5483 Yau Tsim Mong Block 2, The Long Beach 5484 Kwun Tong Dorsett Kwun Tong, Hong Kong 5486 Wan Chai Victoria Heights, 43A Stubbs Road 5487 Islands Tower 3, The Visionary 5488 Sha Tin Yue Chak House, Yue Tin Court 5492 Islands Hong Kong Skycity Marriott Hotel 5496 Tuen Mun King On House, Shan King Estate 5497 Tuen Mun King On House, Shan King Estate 5498 Kowloon City Sik Man House, Ho Man Tin Estate 5499 Wan Chai 168 Tung Lo Wan Road 5500 Sha Tin Block F, Garden Rivera 5501 Sai Kung Clear Water Bay Apartments 5502 Southern Red Hill Park 5503 Sai Kung Po Lam Estate, Po Tai House 5504 Sha Tin Block F, Garden Rivera 5505 Islands Ying Yat House, Yat Tung Estate 5506 Kwun Tong Block 17, Laguna City 5507 Crowne Plaza Hong Kong Kowloon East Sai Kung 5509 Hotel Eastern Tower 2, Pacific Palisades 5510 Kowloon City Billion Court 5511 Yau Tsim Mong Lee Man Building 5512 Central & Western Tai Fat Building 5513 Wan Chai Malibu Garden 5514 Sai Kung Alto Residences 5515 Wan Chai Chee On Building 5516 Sai Kung Block 2, Hillview Court 5517 Tsuen Wan Hoi Pa San Tsuen 5518 Central & Western Flourish Court 5520 1 Related Confirmed / District Building Name Probable Case(s) Wong Tai Sin Fu Tung House, Tung Tau Estate 5521 Yau Tsim Mong Tai Chuen Building, Cosmopolitan Estates 5523 Yau Tsim Mong Yan Hong Building 5524 Sha Tin Block 5, Royal Ascot 5525 Sha Tin Yiu Ping House, Yiu On Estate 5526 Sha Tin Block 5, Royal Ascot 5529 Wan Chai Block E, Beverly Hill 5530 Yau Tsim Mong Tower 1, The Harbourside 5531 Yuen Long Wah Choi House, Tin Wah Estate 5532 Yau Tsim Mong Lee Man Building 5533 Yau Tsim Mong Paradise Square 5534 Kowloon City Tower 3, K.
    [Show full text]
  • CHINA Worries About Rendition Changes Will Be Allayed
    4 | Monday, May 27, 2019 HONG KONG EDITION | CHINA DAILY CHINA Tong blames foreign View from best seat Briefly SHANXI Five drug dealers meddling for growing sentenced to death Five people were sentenced to extradition controversy death for drug dealing by the Jin­ cheng Intermediate People’s By CHEN ZIMO in Hong Kong Court on Friday. Three others [email protected] received death sentences with reprieves, and one received a life Executive Councilor and bar­ Some Hong Kong sentence. The rest of the 23 rister Ronny Tong Ka­wah has individuals and defendants were sentenced to blamed foreign forces for escalat­ three to 16 years’ imprisonment. ing the controversy over planned local media The gang sold 84 kilograms of revisions to Hong Kong’s extradi­ organizations have drugs between September 2016 tion laws. and January 2017. Drug traffick­ Speaking on a local news pro­ utterly strayed from ing is a felony in China. A person gram on Saturday, he said such reality by portraying can receive the death penalty if intervention by other countries convicted of selling or producing has raised the central govern­ the issue as a more than 50 grams of narcotics, ment’s concerns about the issue. political scheme .” such as heroin. As a result, he said it’s unfortu­ nate that trying to turn things Tong Ka-wah , executive BEIJING around at this stage would be dif­ councilor and barrister in Hong Kong SAR Community healthcare ficult. The SAR government proposed workers on the rise changing the Fugitive Offenders They have been misleading the China had 582,000 community and the Mutual Legal Assistance public by deliberately dissemi­ healthcare workers at the end in Criminal Matters Ordinance in nating wrongful information on of 2018, a 5.1 percent increase March in response to a murder the law revision, he said.
    [Show full text]
  • Hong Kong Property: Not Crying Wolf
    Equity Research 28 October 2013 Hong Kong Property Not crying wolf Barclays Capital Inc. and/or one of its affiliates does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. This research report has been prepared in whole or in part by research analysts based outside the US who are not registered/qualified as research analysts with FINRA. PLEASE SEE ANALYST(S) CERTIFICATION(S) AND IMPORTANT DISCLOSURES BEGINNING ON PAGE 132. Barclays | Hong Kong Property HONG KONG PROPERTY Not crying wolf Asia ex-Japan Real Estate First real downturn since 1998, home prices to fall 30% by end-2015E: We initiate Industry view: NEGATIVE coverage of the Hong Kong property sector with a negative view. We believe the property From Neutral market is about to enter its first real downturn since 1998 and we expect home prices to drop by at least 30% by the end of 2015. While we believe consensus also expects prices to decline, we think the magnitude of the fall is underestimated, as are the potential Paul Louie knock-on effects on commercial property. We expect a synchronised downturn, with +852 2903 4545 office prices falling by 20%, while retail properties escape with just zero growth through [email protected] end-2015E. Among the 14 stocks on which we initiate coverage, we rate eight UW, four Barclays Bank, Hong Kong EW and only two OW.
    [Show full text]
  • 1193Rd Minutes
    Minutes of 1193rd Meeting of the Town Planning Board held on 17.1.2019 Present Permanent Secretary for Development Chairperson (Planning and Lands) Ms Bernadette H.H. Linn Professor S.C. Wong Vice-chairperson Mr Lincoln L.H. Huang Mr Sunny L.K. Ho Dr F.C. Chan Mr David Y.T. Lui Dr Frankie W.C. Yeung Mr Peter K.T. Yuen Mr Philip S.L. Kan Dr Lawrence W.C. Poon Mr Wilson Y.W. Fung Dr C.H. Hau Mr Alex T.H. Lai Professor T.S. Liu Ms Sandy H.Y. Wong Mr Franklin Yu - 2 - Mr Daniel K.S. Lau Ms Lilian S.K. Law Mr K.W. Leung Professor John C.Y. Ng Chief Traffic Engineer (Hong Kong) Transport Department Mr Eddie S.K. Leung Chief Engineer (Works) Home Affairs Department Mr Martin W.C. Kwan Deputy Director of Environmental Protection (1) Environmental Protection Department Mr. Elvis W.K. Au Assistant Director (Regional 1) Lands Department Mr. Simon S.W. Wang Director of Planning Mr Raymond K.W. Lee Deputy Director of Planning/District Secretary Ms Jacinta K.C. Woo Absent with Apologies Mr H.W. Cheung Mr Ivan C.S. Fu Mr Stephen H.B. Yau Mr K.K. Cheung Mr Thomas O.S. Ho Dr Lawrence K.C. Li Mr Stephen L.H. Liu Miss Winnie W.M. Ng Mr Stanley T.S. Choi - 3 - Mr L.T. Kwok Dr Jeanne C.Y. Ng Professor Jonathan W.C. Wong Mr Ricky W.Y. Yu In Attendance Assistant Director of Planning/Board Ms Fiona S.Y.
    [Show full text]
  • ATTACHMENT 1 Barcode:3800584-02 C-570-107 INV - Investigation
    ATTACHMENT 1 Barcode:3800584-02 C-570-107 INV - Investigation - Chinese Producers of Wooden Cabinets and Vanities Company Name Company Information Company Name: A Shipping A Shipping Street Address: Room 1102, No. 288 Building No 4., Wuhua Road, Hongkou City: Shanghai Company Name: AA Cabinetry AA Cabinetry Street Address: Fanzhong Road Minzhong Town City: Zhongshan Company Name: Achiever Import and Export Co., Ltd. Street Address: No. 103 Taihe Road Gaoming Achiever Import And Export Co., City: Foshan Ltd. Country: PRC Phone: 0757-88828138 Company Name: Adornus Cabinetry Street Address: No.1 Man Xing Road Adornus Cabinetry City: Manshan Town, Lingang District Country: PRC Company Name: Aershin Cabinet Street Address: No.88 Xingyuan Avenue City: Rugao Aershin Cabinet Province/State: Jiangsu Country: PRC Phone: 13801858741 Website: http://www.aershin.com/i14470-m28456.htmIS Company Name: Air Sea Transport Street Address: 10F No. 71, Sung Chiang Road Air Sea Transport City: Taipei Country: Taiwan Company Name: All Ways Forwarding (PRe) Co., Ltd. Street Address: No. 268 South Zhongshan Rd. All Ways Forwarding (China) Co., City: Huangpu Ltd. Zip Code: 200010 Country: PRC Company Name: All Ways Logistics International (Asia Pacific) LLC. Street Address: Room 1106, No. 969 South, Zhongshan Road All Ways Logisitcs Asia City: Shanghai Country: PRC Company Name: Allan Street Address: No.188, Fengtai Road City: Hefei Allan Province/State: Anhui Zip Code: 23041 Country: PRC Company Name: Alliance Asia Co Lim Street Address: 2176 Rm100710 F Ho King Ctr No 2 6 Fa Yuen Street Alliance Asia Co Li City: Mongkok Country: PRC Company Name: ALMI Shipping and Logistics Street Address: Room 601 No.
    [Show full text]
  • Thailand) PCL, 45% (Of Paid-Up Capital)
    Annual Report 2018 2018 ANNUAL REPORT PP PRIME PUBLIC COMPANY LIMITED PP PRIME PUBLIC COMPANY LIMITED Head Office: 69/5 Moo 5 Rama 2 Road, Bang Khan Taek, EMPOWERING Muangsamut Songkhram, Samut Songkhram 75000 FOR SUSTAINABILITY PP Prime Public Company Limited 1 3 4 7 8 18 34 37 43 44 45 64 75 95 96 99 100 111 112 118 2 Annual Report 2018 PP Prime Public Company Limited 3 4 Annual Report 2018 PP Prime Public Company Limited 5 Board of Directors 6 Annual Report 2018 Board of Directors Financial Information 2018 2017 2016 Sales (Baht) 2,121,449,514 1,875,523,686 2,240,181,809 Net Profit (Loss) (Baht) (110,084,444) (252,406,913) 232,314,148 Earning (Loss)per Share (Baht) (0.20) (0.45) 0.41 Total Asset (Baht) 3,339,876,952 3,987,770,023 3,569,307,914 Total Liabilities (Baht) 2,526,867,363 2,610,754,228 1,749,962,003 Shareholders’ Equity (Baht) 813,009,589 1,377,015,795 1,819,345,911 Book Value (Baht) 1.44 2.45 3.23 Return on Asset (%) (3.00) (6.68) 6.51 Return on Equity (%) (10.05) (15.79) 12.77 Debt to Shareholders (times) 3.11 1.90 0.96 Dividend Yield (%) 0.00 0.00 0.00 P/E Ratio (times) 0.00 0.00 0.00 PP Prime Public Company Limited 7 Policy and Business Overview ภาพรวมธุรกิจ Future TLUXE Food Farm The company focuses on developing the tiger shrimp for sale. During the past 30 years or so, the business in line with the full-cycle strategy i.e.
    [Show full text]
  • List of Buildings with Confirmed / Probable Cases of COVID-19
    List of Buildings With Confirmed / Probable Cases of COVID-19 List of Residential Buildings in Which Confirmed / Probable Cases Have Resided (Note: The buildings will remain on the list for 14 days since the reported date.) Related Confirmed / District Building Name Probable Case(s) Wan Chai Block C, Fontana Garden 5868 Yau Tsim Mong Cam Key Mansion, 495 Shanghai Street 5869 Kowloon City Crystal Mansion 5870 Central & Western Best Western Plus Hotel Hong Kong 5871 Central & Western Tower 1, Kong Chian Tower 5872 Wan Chai 11 Broom Road 5873 Kwai Tsing Wah Shun Court 5874 Kowloon City Sunderland Estate 5875 Islands Headland Hotel 5877 Eastern Block A, Yen Lok Building 5879 Sha Tin Hin Kwai House, Hin Keng Estate 5880 Tai Po Po Sam Pai Village 5881 Sha Tin Mei Chi House, Mei Tin Estate 5882 Tsuen Wan Block 2, Waterside Plaza 5882 Sha Tin Jubilee Court, Jubilee Garden 5883 Kwun Tong Lee Ming House, Shun Lee Estate 5884 Southern Tower 9, Bel-Air On The Peak 5885 Central & Western Block 3, Garden Terrace 5886 Sai Kung Tower 5, The Mediterranean 5887 Sai Kung Tower 5, The Mediterranean 5888 Kowloon City Block 1, Kiu Wang Mansion 5889 Islands Heung Yat House, Yat Tung Estate 5890 Sha Tin Cypress House, Kwong Yuen Estate 5891 Kwai Tsing Block 6, Mayfair Gardens 5892 Eastern Tower 1, Harbour Glory 5893 Sai Kung Kap Pin Long 5894 Wan Chai Hawthorn Garden 5895 Tai Po Villa Castell 5896 Kwun Tong Ping Shun House, Ping Tin Estate 5897 Sai Kung Tak Fu House, Hau Tak Estate 5898 Kwai Tsing Ying Kwai House, Kwai Chung Estate 5899 1 Related Confirmed /
    [Show full text]
  • CSR90 the United States, China, and Taiwan
    Council Special Report No. 90 February 2021 The United States, Cover photo: A red pin indicates Taiwan on a map of East Asia. (hyotographics/Shutterstock) China, and Taiwan: Council on Foreign Relations cfr.org A Strategy to Prevent War 58 East 68th Street 1777 F Street, NW New York, NY 10065 Washington, DC 20006 tel 212.434.9400 tel 202.509.8400 Robert D. Blackwill and Philip Zelikow Council Special Report No. 90 February 2021 The United States, China, and Taiwan: A Strategy to Prevent War Robert D. Blackwill and Philip Zelikow The Council on Foreign Relations (CFR) is an independent, nonpartisan membership organization, think tank, and publisher dedicated to being a resource for its members, government officials, business executives, journalists, educators and students, civic and religious leaders, and other interested citizens in order to help them better understand the world and the foreign policy choices facing the United States and other countries. Founded in 1921, CFR carries out its mission by maintaining a diverse membership, with special programs to promote interest and develop expertise in the next generation of foreign policy leaders; convening meetings at its headquarters in New York and in Washington, DC, and other cities where senior government officials, members of Congress, global leaders, and prominent thinkers come together with Council members to discuss and debate major international issues; supporting a Studies Program that fosters independent research, enabling CFR scholars to produce articles, reports, and books and hold roundtables that analyze foreign policy issues and make concrete policy recommendations; publishing Foreign Affairs, the preeminent journal on international affairs and U.S.
    [Show full text]
  • Securing the Belt and Road Initiative: China's Evolving Military
    the national bureau of asian research nbr special report #80 | september 2019 securing the belt and road initiative China’s Evolving Military Engagement Along the Silk Roads Edited by Nadège Rolland cover 2 NBR Board of Directors John V. Rindlaub Kurt Glaubitz Matt Salmon (Chairman) Global Media Relations Manager Vice President of Government Affairs Senior Managing Director and Chevron Corporation Arizona State University Head of Pacific Northwest Market East West Bank Mark Jones Scott Stoll Co-head of Macro, Corporate & (Treasurer) Thomas W. Albrecht Investment Bank, Wells Fargo Securities Partner (Ret.) Partner (Ret.) Wells Fargo & Company Ernst & Young LLP Sidley Austin LLP Ryo Kubota Mitchell B. Waldman Dennis Blair Chairman, President, and CEO Executive Vice President, Government Chairman Acucela Inc. and Customer Relations Sasakawa Peace Foundation USA Huntington Ingalls Industries, Inc. U.S. Navy (Ret.) Quentin W. Kuhrau Chief Executive Officer Charles W. Brady Unico Properties LLC Honorary Directors Chairman Emeritus Lawrence W. Clarkson Melody Meyer Invesco LLC Senior Vice President (Ret.) President The Boeing Company Maria Livanos Cattaui Melody Meyer Energy LLC Secretary General (Ret.) Thomas E. Fisher Long Nguyen International Chamber of Commerce Senior Vice President (Ret.) Chairman, President, and CEO Unocal Corporation George Davidson Pragmatics, Inc. (Vice Chairman) Joachim Kempin Kenneth B. Pyle Vice Chairman, M&A, Asia-Pacific (Ret.) Senior Vice President (Ret.) Professor, University of Washington HSBC Holdings plc Microsoft Corporation Founding President, NBR Norman D. Dicks Clark S. Kinlin Jonathan Roberts Senior Policy Advisor President and Chief Executive Officer Founder and Partner Van Ness Feldman LLP Corning Cable Systems Ignition Partners Corning Incorporated Richard J.
    [Show full text]
  • Febrúar 2021
    Hugverka tíðindi 38. árg | 2. tbl | 15. feb. 2021 Útgefandi: Hugverkastofan Ábyrgðarmaður: Borghildur Erlingsdóttir Afgreiðsla: Engjateigi 3, 105 Reykjavík Sími: 580 9400, Bréfasími: 580 9401 Afgreiðslutími: kl. 10-15 virka daga Heimasíða: www.hugverk.is Áskriftargjald: 4.300,- Verð í lausasölu: kr. 500,- eintakið Rafræn útgáfa: ISSN 1670-0104 Efnisyfirlit Vörumerki Einkaleyfi Skráð landsbundin vörumerki.......................................... 4 Veitt einkaleyfi (B)…………………………………………………….. 164 Birt landsbundin vörumerki………………………………………. 8 Evrópsk einkaleyfi í gildi á Íslandi (T3)............................ 165 Alþjóðlegar vörumerkjaskráningar.................................. 40 Breytt útgáfa evrópskra einkaleyfa í gildi á Íslandi eftir takmörkun (T4)……….………...……………………………………… 178 Breytingar í vörumerkjaskrá...……………………………….…… 58 Beiðni um endurveitingu…………………………………………… 179 Breyting skv. 54 gr. laga nr. 45/1997 um vörumerki…... 71 Umsóknir um viðbótarvernd (I1)……………….……………….. 180 Takmarkanir og viðbætur………………………………………….. 72 Veitt viðbótarvottorð (I2)…………………………………………… 181 Framsöl að hluta………………………………………………………. 73 Framlenging á viðbótarvottorði…………………………………. 182 Veðsetning vörumerkja…………………………………………….. 74 Breytingar í einkaleyfaskrá............................................... 183 Endurnýjuð vörumerki………………………………………………. 75 Leiðréttingar..................................................................... 185 Afmáð vörumerki……………………………………………………… 76 Andmæli………………………………………………………………….. 77 Úrskurðir í áfrýjunarmálum……………………………………….. 78 Hönnun
    [Show full text]
  • Updated: Sep 14, 2020
    Updated: Sep 14, 2020 ASHK members receive valuable offers and discounts from more than 30 selected retailers in Hong Kong. To enjoy these exclusive privileges, simply present your valid ASHK membership card at the participating outlets. Please check our website for the latest offers! Enjoy 10% discount on regular-priced items to 45R 45R has surpassed fashion and adhering to its belief in the beauty of nostalgia and quality craftsmanship. The timeless designs feel like an old favorite at the very first time it is worn and it is of such quality that 45R clothing can be passed on from generation to generation. Exquisite materials and craftsmanship conveys the luxurious-causal styling to daily life. Terms and conditions apply: - Promotion cannot be used in conjunction with any other promotions - Please present Asia Society Hong Kong Center Membership Card to shop staff before billing Shop Directory: - Valid until 31 December 2020 7, Star Street, Wan Chai, Tel: 2861 1145 - Benefits are subject to change without prior notice and Sidefame Shop 3083, IFC Mall, Tel: 2556 9745 Ltd reserves the right to decide on the eligibility of benefits Shop 201, The Lee Gardens One, Tel: 2504 2445 Shop 2515, Harbour City Tel: 2175 5545 Enjoy 15% discount at AMMO Residing at the Asia Society Hong Kong Center, AMMO is an Italian Japanese fusion restaurant inspired by the botanical surroundings. From today onwards, all ASHK members enjoy 15% off upon presentation of a valid Asia Society Hong Kong Center membership card when settling the bill. Hope you enjoy this new exclusive offers available to ASHK members only.
    [Show full text]